KW-2450 free base Completed Phase 1 Trials for Tumors, Solid Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00921336Safety Study to Evaluate KW-2450 in Subjects With Advanced Solid Tumor